This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Aetna Collaborates With CVS Caremark And Dovetail Health To Help Members Manage Their Prescriptions

Stocks in this article: AET CVS

HARTFORD, Conn. and WOONSOCKET, R.I., Aug. 20, 2013 /PRNewswire/ -- Aetna (NYSE: AET) announced today a new pilot program called the Aetna Rx Home Success Program SM.  Supported by CVS Caremark (NYSE: CVS), the Aetna Rx Home Success Program works with CVS Caremark pharmacists and Dovetail Health to support Aetna members who are taking multiple medications. The program helps members manage their health through personal support from a pharmacist – including offering in-home consultations -- and focuses on those who have recently been discharged from a hospital, nursing home or rehabilitation facility.

(Logo: http://photos.prnewswire.com/prnh/20090226/NE75914LOGO) (Logo:  http://photos.prnewswire.com/prnh/20130820/NE66096LOGO)

How The Aetna Rx Home Success Program Works Members who decide to enroll in the Aetna Rx Home Success Program are contacted by a pharmacist who will work with them to schedule an in-home visit or a detailed phone consultation. The pharmacist will review any new and/or pre-existing medications and help create a detailed care plan with the member and their doctor. The pharmacist will address potential medication-related issues, identify gaps in care, and educate members about their medicine(s). The pharmacist will also consider other risk factors, including chronic conditions, home safety, and will aid in arranging physician follow-up visits.

"We are very excited to partner with CVS Caremark and Dovetail Health on this program. By providing a personalized approach to health care we can help our members stay on track with their medications, educate them about their treatment, and prevent a repeated trip to the hospital," said Dr. William Fried, senior medical director of Aetna's Southeast Region.

More Than 1 In 4 Members Are At Risk 1 Hospital readmissions due to not properly taking their medication affect nearly 3.5 million patients and result in about $15.2 billion dollars in health care costs each year 2. Aetna's innovative approach to health care, blending the expertise of CVS Caremark and a Dovetail Health pharmacist, provides a complete circle of care, ensuring positive health outcomes for its members.

"We look forward to piloting this program with Aetna as high rates of hospital readmissions result in increased costs for the patient and the payor, which can negatively impact a patient's health outcomes," said Troyen A. Brennan, M.D., M.P.H., executive vice president and chief medical officer for CVS Caremark. "Many patients who are newly discharged from a hospital or rehab facility are taking multiple medications. Trying to navigate multiple treatment guidelines provided by the patient's primary care physician and the treatment facility discharge team can be overwhelming. Our research shows that the intervention of a clinical pharmacist helps patients better understand their medications and avoid potential setbacks to recovery after returning home."

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,164.95 -251.90 -1.45%
S&P 500 1,994.99 -26.26 -1.30%
NASDAQ 4,635.24 -48.1670 -1.03%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs